Thomas Schall
Director/Board Member presso IMMUNEERING CORPORATION
Patrimonio netto: 8 381 $ in data 31/03/2024
Profilo
Thomas J.
Schall is the founder of ChemoCentryx, Inc., a company founded in 1997.
He held the title of Chairman, President & Chief Executive Officer from 2012 to 2022.
Dr. Schall is currently working as a Director at Immuneering Corp.
since 2024.
In the past, he worked as a Scientist at Genentech, Inc. and as a Principal at DNAX Research, Inc. Dr. Schall obtained a doctorate degree from Stanford University and an undergraduate degree from Northern Illinois University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 22/03/2024 | 2 900 ( 0.01% ) | 8 381 $ | 31/03/2024 |
Posizioni attive di Thomas Schall
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNEERING CORPORATION | Director/Board Member | 12/03/2024 |
Precedenti posizioni note di Thomas Schall
| Società | Posizione | Fine |
|---|---|---|
| CHEMOCENTRYX, INC. | Chief Executive Officer | 20/10/2022 |
| DNAX Research, Inc. | Corporate Officer/Principal | 01/01/1997 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
Formazione di Thomas Schall
| Stanford University | Doctorate Degree |
| Northern Illinois University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| IMMUNEERING CORPORATION | Health Technology |
| Aziende private | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
| DNAX Research, Inc. |
- Borsa valori
- Insiders
- Thomas Schall
